natgillin/translations-raw huggingface dataset:
In addition, the exemption provided for in point 18 of Annex V to Regulation (EU) No 1169/2011 should not apply and the nutrition declaration should be mandatory for all infant formula and follow-on formula, irrespective of the package or container size.
Poleg tega se izvzetje iz točke 18 Priloge V k Uredbi (EU) št. 1169/2011 ne bi smelo uporabljati in označba hranilne vrednosti bi morala biti obvezna za vse začetne formule za dojenčke in nadaljevalne formule, ne glede na velikost embalaže ali posode.
Article 30(2) of Regulation (EU) No 1169/2011 contains a limited list of nutrients that may be included on a voluntary basis in the nutrition declaration for food.
Člen 30(2) Uredbe (EU) št. 1169/2011 vsebuje omejen seznam hranilnih snovi, ki se lahko prostovoljno vključijo v označbo hranilne vrednosti za živila.
That Article does not cover all the substances that may be added to infant formula and follow-on formula.
Navedeni člen ne zajema vseh snovi, ki jih je mogoče dodati začetnim formulam za dojenčke in nadaljevalnim formulam.
In order to ensure legal clarity, it should be laid down explicitly that the nutrition declaration for infant formula and follow-on formula may include such substances.
Zaradi pravne jasnosti bi bilo treba izrecno določiti, da označba hranilne vrednosti za začetne formule za dojenčke in nadaljevalne formule lahko vključuje take snovi.
In addition, in certain cases, more detailed information on protein, carbohydrate and fat present in the product could provide additional useful information for parents, caregivers and healthcare professionals.
Poleg tega bi v nekaterih primerih podrobnejše informacije o beljakovinah, ogljikovih hidratih in maščobah v proizvodu lahko pomenile dodatne koristne informacije za starše, skrbnike in zdravstvene delavce.
Food business operators should therefore be allowed to provide such information on a voluntary basis.
Nosilcem živilske dejavnosti bi se zato moralo omogočiti, da prostovoljno poskrbijo za take informacije.
In order to facilitate product comparisons, the nutrition declaration for infant formula and follow-on formula should be expressed per 100 ml of the product ready for use after preparation in accordance with the manufacturer's instructions.
Zaradi lažje primerjave proizvodov bi bilo označbo hranilne vrednosti za začetne formule za dojenčke in nadaljevalne formule treba navajati za 100 ml obroka, pripravljenega za uporabo po pripravi v skladu s proizvajalčevimi navodili.
Infant formula is a food intended for use by infants during the first months of life and satisfying by itself the nutritional requirements of such infants until the introduction of appropriate complementary feeding.
Začetne formule za dojenčke so živilo, ki je namenjeno dojenčkom v prvih mesecih življenja in samo po sebi zadovolji prehranske potrebe takih dojenčkov do uvedbe ustrezne dopolnilne hrane.
The expression of nutrition information on the energy value and the amount of nutrients of infant formula as a percentage of daily reference intake values would mislead consumers and should therefore not be allowed.
Navajanje informacij o hranilni vrednosti z energijo in količino hranil v začetnih formulah za dojenčke kot odstotek vrednosti dnevnega priporočenega vnosa bi zavajalo potrošnike in zato ne bi smelo biti dovoljeno.
Follow-on formula is, on the contrary, a food intended for use by infants when appropriate complementary feeding is introduced and which constitutes the principal liquid element in a progressively diversified diet of such infants.
Nadaljevalne formule so v nasprotju s tem živilo, ki je namenjeno dojenčkom ob začetku uvajanja ustrezne dopolnilne hrane in je glavni tekoči del postopoma raznovrstnejše prehrane takih dojenčkov.
For that reason, and in order to ensure comparisons with other foods that can be included in the diet of such infants, the expression of nutrition information for follow-on formula as a percentage of daily reference intake values should be allowed.
Zaradi tega in zaradi primerjave z drugimi živili, ki so lahko sestavni del prehrane takih dojenčkov, bi pri nadaljevalnih formulah navajanje informacij o hranilni vrednosti kot odstotek vrednosti dnevnega priporočenega vnosa moralo biti dovoljeno.
Given that healthy infants have different nutritional needs than adults, the use of daily reference intake values set out for the general adult population in Regulation (EU) No 1169/2011 would mislead consumers and should therefore not be allowed.
Ker imajo zdravi dojenčki različne prehranske potrebe od odraslih, bi uporaba vrednosti dnevnega priporočenega vnosa za splošno odraslo prebivalstvo iz Uredbe (EU) št. 1169/2011 zavajala potrošnike in zato ne bi smela biti dovoljena.
For follow-on formula it should only be allowed to express nutrition information as a percentage of specific reference intakes that are appropriate for the age group.
Za nadaljevalne formule bi moralo biti dovoljeno samo navajanje informacij o hranilni vrednosti kot odstotek specifičnih priporočenih vnosov, primernih za to starostno skupino.
Nutrition and health claims are promotional tools that are used on a voluntary basis by food business operators in commercial communication, in line with the rules of Regulation (EC) No 1924/2006 of the European Parliament and of the Council [9].
Prehranske in zdravstvene trditve so pripomočki za promocijo, ki jih prostovoljno uporabljajo nosilci živilske dejavnosti pri tržnem komuniciranju v skladu z določbami Uredbe (ES) št. 1924/2006 Evropskega parlamenta in Sveta [9].
Given the particular role of infant formula in the diet of infants, the use of nutrition and health claims should not be allowed for infant formula.
Glede na posebno vlogo začetnih formul za dojenčke v njihovi prehrani uporaba prehranskih in zdravstvenih trditev ne bi smela biti dovoljena za začetne formule za dojenčke.
Statements relating to the presence or absence of lactose in infant formula and follow-on formula can provide useful information to parents and caregivers.
Izjave o vsebnosti ali nevsebnosti laktoze v začetnih formulah za dojenčke in nadaljevalnih formulah lahko pomenijo koristne informacije za starše in skrbnike.
Therefore, it is appropriate to lay down rules on such statements, which might be reviewed taking account of future developments on the market.
Zato je primerno, da se določijo pravila za take izjave, ki jih bo morda treba pregledati ob upoštevanju prihodnjega razvoja dogodkov na trgu.
The mandatory addition of docosahexaenoic acid (DHA) to infant formula and follow-on formula is a new requirement introduced by this Regulation, as recently recommended by the Authority in its opinion on the essential composition of infant and follow-on formulae.
Obvezno dodajanje dokozaheksaenojske kisline (v nadaljnjem besedilu: DHK) začetnim formulam za dojenčke in nadaljevalnim formulam je nova zahteva, ki jo uvaja ta uredba, kot je nedavno priporočila Agencija v svojem mnenju o osnovni sestavi začetnih formul za dojenčke in nadaljevalnih formul.
Given that the addition of DHA was allowed on a voluntary basis under Directive 2006/141/EC, and parents and caregivers are familiar with the nutrition claim about the presence of DHA in infant formula, the use of which was permitted under that Directive, food business operators should be allowed to continue to refer to the presence of DHA in infant formula by a statement provided for in this Regulation for a limited period of time in order to avoid confusion.
Ker je bilo dodajanje DHK dovoljeno kot prostovoljna možnost v skladu z Direktivo 2006/141/ES ter starši in skrbniki poznajo prehransko trditev o vsebnosti DHK v začetnih formulah za dojenčke, katere uporaba je dovoljena v skladu z navedeno direktivo, bi bilo treba nosilcem živilske dejavnosti omogočiti, da za omejeno obdobje še naprej navajajo vsebnost DHK v začetnih formulah za dojenčke z izjavo, določeno s to uredbo, da bi se izognili zmedi.
However, it is important that that statement provides full information to consumers about the mandatory presence of DHA in all infant formula products on the market.
Vendar je pomembno, da navedena izjava potrošnikom daje popolne informacije o obvezni vsebnosti DHK v vseh proizvodih z začetnimi formulami za dojenčke na trgu.
The use of protein hydrolysates as a source of protein in infant formula and follow-on formula has been allowed under Directive 2006/141/EC for many years and the use of protein hydrolysates in the manufacturing of formula is widespread in the market.
Uporaba beljakovinskih hidrolizatov kot vira beljakovin v začetnih formulah za dojenčke in nadaljevalnih formulah je več let dovoljena na podlagi Direktive 2006/141/ES, uporaba beljakovinskih hidrolizatov pri proizvodnji formul pa je zelo razširjena na trgu.
This is due, in particular, to the possibility, recognised by that Directive, to make a health claim on infant formula manufactured from protein hydrolysates describing the role of such formula in reducing the risk of developing allergy to milk proteins, under certain conditions laid down in that Directive.
To izhaja zlasti iz možnosti, ki jo priznava navedena direktiva, da se na začetnih formulah za dojenčke, izdelanih iz beljakovinskih hidrolizatov, pod nekaterimi pogoji iz navedene direktive navede zdravstvena trditev, ki opisuje vlogo takih formul pri zmanjševanju tveganja za razvoj alergij na mlečne beljakovine.
In its opinion on the essential composition of infant and follow-on formulae, the Authority noted that the safety and suitability of each specific formula containing protein hydrolysates has to be established by clinical evaluation and that only one formula containing partially hydrolysed whey protein has been positively evaluated so far.
V mnenju o osnovni sestavi začetnih formul za dojenčke in nadaljevalnih formul je Agencija navedla, da je varnost in primernost vsake posebne formule, ki vsebuje beljakovinske hidrolizate, treba ugotoviti s klinično oceno in je doslej bila pozitivno ocenjena samo ena formula, ki vsebuje delno hidrolizirane beljakovine sirotke.
The Authority also noted that clinical studies are necessary to demonstrate if and to what extent a particular formula reduces the risk of developing short and long-term clinical manifestations of allergy in at-risk-infants who are not breast-fed.
Agencija je tudi navedla, da so klinične študije potrebne za dokaz, ali in koliko posebna formula zmanjšuje tveganje kratkoročnega in dolgoročnega razvoja kliničnih znakov alergije pri ogroženih dojenčkih, ki se ne dojijo.
Taking into account the Authority's opinion, infant formula and follow-on formula manufactured from protein hydrolysates should only be allowed to be placed on the market if their composition corresponds to the requirements of this Regulation.
Ob upoštevanju mnenja Agencije bi se začetne formule za dojenčke in nadaljevalne formule, izdelane iz beljakovinskih hidrolizatov, lahko dale v promet, samo če njihova sestava ustreza zahtevam te uredbe.
Those requirements may be updated in order to allow the placing on the market of formula manufactured from protein hydrolysates with a composition different from the one already positively assessed, following a case-by-case evaluation of their safety and suitability by the Authority.
Navedene zahteve se lahko dopolnijo, da se dovoli dajanje v promet formule, ki je izdelana iz beljakovinskih hidrolizatov in ima različno sestavo od že pozitivno ocenjenih formul, potem ko Agencija oceni varnost in primernost vsakega primera posebej.
In addition, after the assessment by the Authority, on the basis of studies, where it is demonstrated that a specific formula manufactured from protein hydrolysates reduces the risk of developing allergy to milk proteins, further consideration will be given to how to adequately inform parents and caregivers about that property of the product.
Po oceni Agencije na podlagi študij se poleg tega, kadar je dokazano, da posebna formula, izdelana iz beljakovinskih hidrolizatov, zmanjšuje tveganje za razvoj alergije na mlečne beljakovine, dodatno preuči, kako ustrezno obvestiti starše in skrbnike o navedeni lastnosti proizvoda.
Regulation (EU) No 609/2013 provides that the labelling, presentation and advertising of infant formula and follow-on formula is to be designed so as not to discourage breastfeeding.
Uredba (EU) št. 609/2013 določa, da morajo biti označevanje, predstavitev in oglaševanje začetnih formul za dojenčke in nadaljevalnih formul zasnovani tako, da ne odvračajo od dojenja.
There is scientific consensus that breast milk is the preferred food for healthy infants and the Union and its Member States are continuously committed to supporting breastfeeding.
Znanstveniki se strinjajo, da ima materino mleko prednost kot hrana za zdrave dojenčke, Unija in njene države članice pa se ves čas zavzemajo za podporo dojenju.
The conclusions adopted by the Council on nutrition and physical activity [10] invited Member States to promote and support adequate breastfeeding and welcomed the Member States' agreement on an EU Action Plan on Childhood Obesity 2014-2020, which includes a series of actions aimed at increasing breastfeeding rates in the Union.
Svet je sprejel sklepe o prehrani in telesni dejavnosti [10], s katerimi poziva države članice, da spodbujajo in podpirajo ustrezno dojenje, ter pozdravlja dogovor držav članic za akcijski načrt EU o debelosti otrok za obdobje 2014–2020, ki vključuje vrsto ukrepov za povečanje deležev dojenja v Uniji.
In this context, the EU Action Plan recognised the continuous importance of the World Health Organisation (WHO) International Code of Marketing of Breast-milk Substitutes, on which Directive 2006/141/EC was based.
Pri tem se v akcijskem načrtu EU priznava trajni pomen Mednarodnega kodeksa za trženje nadomestkov za materino mleko Svetovne zdravstvene organizacije (v nadaljnjem besedilu: SZO), na katerem temelji Direktiva 2006/141/ES.
The WHO Code, adopted by the 34th World Health Assembly, aims at contributing to the provision of safe and adequate nutrition for infants, by the protection and promotion of breast-feeding, and by ensuring the proper use of breast-milk substitutes.
Namen Kodeksa SZO, ki ga je sprejela 34. generalna skupščina Svetovne zdravstvene organizacije, je prispevati k varni in ustrezni prehrani za dojenčke z varovanjem in spodbujanjem dojenja ter zagotovitvijo pravilne uporabe nadomestkov materinega mleka.
It includes a series of principles related to, among others, marketing, information and responsibilities of health authorities.
Med drugim vključuje več načel o trženju, obveščanju in odgovornosti zdravstvenih organov.
In order to protect the health of infants, the rules laid down in this Regulation and in particular those on labelling, presentation and advertising, and promotional and commercial practices should continue being in conformity with the principles and the aims of the International Code of Marketing of Breast-milk Substitutes bearing in mind the particular legal and factual situation existing in the Union.
Da bi zaščitili zdravje dojenčkov, bi morala pravila iz te uredbe, zlasti pravila o označevanju, predstavljanju in oglaševanju, ter promocijske in trgovinske prakse še naprej ostati v skladu z načeli in cilji Mednarodnega kodeksa za trženje nadomestkov za materino mleko ob upoštevanju posebnih pravnih in siceršnjih razmer v Uniji.
In particular, evidence shows that advertising directly to the consumer and other marketing techniques influence parents and caregivers in their decisions on how to feed their infants.
Natančneje, podatki kažejo, da neposredno oglaševanje pri potrošniku in druge tehnike trženja vplivajo na starše in skrbnike pri odločanju, kako hraniti svoje otroke.
For this reason, and taking into account the particular role of infant formula in the diet of infants, specific restrictions should be laid down in this Regulation on advertising and other marketing techniques for this type of product.
Iz tega razloga in ob upoštevanju posebne vloge začetnih formul za dojenčke v njihovi prehrani bi v tej uredbi bilo treba določiti posebne omejitve pri oglaševanju in drugih tehnikah trženja za to vrsto proizvoda.
However, this Regulation should not concern the conditions of sale of publications specialising in baby care and of scientific publications.
Ta uredba pa ne bi smela obravnavati pogojev za prodajo publikacij, specializiranih za nego dojenčkov, in znanstvenih publikacij.
In addition, information given on infant and young child feeding influences pregnant women, parents and caregivers when choosing the type of nourishment for children.
Poleg tega informacije o hranjenju dojenčkov in majhnih otrok vplivajo na nosečnice, starše in skrbnike, ko izbirajo vrsto prehrane za otroke.
It is therefore necessary to lay down requirements in order that such information ensures an adequate use of the products in question and is not counter to the promotion of breast feeding, in line with the principles of the WHO code.
Zato je treba določiti zahteve, s katerimi bi te informacije zagotovile primerno uporabo zadevnih proizvodov in ne bi bile v nasprotju s spodbujanjem dojenja v skladu z načeli Kodeksa SZO.
Article 17(2) of Regulation (EC) No 178/2002 of the European Parliament and of the Council [11] requires Member States to enforce food law, and monitor and verify that the relevant requirements of food law are fulfilled by food and feed business operators at all stages of production, processing and distribution.
Člen 17(2) Uredbe (ES) št. 178/2002 Evropskega parlamenta in Sveta [11] od držav članic zahteva, da zagotovijo izvajanje živilske zakonodaje ter spremljajo in preverjajo, da nosilci živilske dejavnosti in dejavnosti proizvodnje krme v vseh fazah pridelave, predelave in distribucije izpolnjujejo ustrezne zahteve živilske zakonodaje.
In this context, in order to facilitate the efficient official monitoring of infant formula and follow-on formula, food business operators placing infant formula on the market should provide the national competent authorities with a model of the label used and all relevant information considered necessary to demonstrate compliance with this Regulation.
V zvezi s tem morajo nosilci živilske dejavnosti, ki dajo v promet začetne formule za dojenčke, pristojnim nacionalnim organom predložiti vzorec uporabljenega označevanja z vsemi ustreznimi informacijami, ki se zdijo potrebne za dokazovanje skladnosti s to uredbo, da bi se olajšalo učinkovito uradno spremljanje začetnih formul za dojenčke in nadaljevalnih formul.
A similar obligation should apply in respect of certain types of follow-on formula, unless Member States have a different efficient monitoring system.
Podobna obveznost bi morala veljati za nekatere vrste nadaljevalnih formul, razen če imajo države članice različen učinkovit sistem spremljanja.
In order to enable food business operators to adapt to the new requirements, this Regulation should apply from a date that is four years after its entry into force.
Da bi nosilcem živilske dejavnosti omogočili, da se prilagodijo novim zahtevam, bi se ta uredba morala začeti uporabljati štiri leta po datumu začetka veljavnosti.
Taking into account the number and importance of the new requirements applicable to infant formula and follow-on formula manufactured from protein hydrolysates, in respect of such products this Regulation should apply from a date that is five years after its entry into force,
Zaradi števila in pomembnosti novih zahtev, ki se uporabljajo za začetne formule za dojenčke in nadaljevalne formule, izdelane iz beljakovinskih hidrolizatov, bi se ta uredba za take proizvode morala začeti uporabljati pet let po datumu začetka veljavnosti –
Infant formula and follow-on formula may only be placed on the market if they comply with this Regulation.
Začetne formule za dojenčke in nadaljevalne formule se smejo dati v promet, samo če so v skladu s to uredbo.
No product other than infant formula may be marketed or otherwise represented as suitable for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life until the introduction of appropriate complementary feeding.
Razen začetnih formul za dojenčke se noben proizvod ne sme tržiti ali kako drugače predstavljati kot primeren, da sam po sebi zadovoljuje prehranske potrebe normalnih zdravih dojenčkov v prvih mesecih življenja do uvedbe ustrezne dopolnilne hrane.
Compositional requirements
Zahteve glede sestave
Infant formula shall comply with the compositional requirements set out in Annex I taking into account the values for the indispensable and conditionally indispensable amino acids set out in Annex III.
Začetne formule za dojenčke morajo biti v skladu z zahtevami glede sestave iz Priloge I, pri čemer se upoštevajo vrednosti za nepogrešljive ali pogojno nepogrešljive aminokisline iz Priloge III.
Follow-on formula shall comply with the compositional requirements set out in Annex II taking into account the values for the indispensable and conditionally indispensable amino acids set out in Annex III.
Nadaljevalne formule morajo biti v skladu z zahtevami glede sestave iz Priloge II, pri čemer se upoštevajo vrednosti za nepogrešljive ali pogojno nepogrešljive aminokisline iz Priloge III.
The values set out in Annexes I and II shall apply to the infant formula and follow-on formula ready for use, marketed as such or after preparation in accordance with the manufacturer's instructions.
Vrednosti iz prilog I in II se uporabljajo za začetne formule za dojenčke in nadaljevalne formule, ki so pripravljene za uporabo in se tržijo kot take ali po pripravi v skladu s proizvajalčevimi navodili.
For such preparation nothing more than the addition of water shall be required.
Za tako pripravo se ne sme zahtevati nič drugega razen dodajanja vode.
Suitability of ingredients
Primernost sestavin
Infant formula shall be manufactured from protein sources as set out in point 2 of Annex I and other food ingredients, as the case may be, whose suitability for infants from birth has been established by generally accepted scientific data.
Začetne formule za dojenčke se glede na okoliščine proizvajajo iz virov beljakovin iz točke 2 Priloge I in drugih živilskih sestavin, za katere splošno sprejeti znanstveni podatki kažejo, da so primerne za dojenčke od njihovega rojstva.
Follow-on formula shall be manufactured from protein sources as set out in point 2 of Annex II and other food ingredients, as the case may be, whose suitability for infants aged over six months has been established by generally accepted scientific data.
Nadaljevalne formule se glede na okoliščine proizvajajo iz virov beljakovin iz točke 2 Priloge II in drugih živilskih sestavin, za katere splošno sprejeti znanstveni podatki kažejo, da so primerne za dojenčke, starejše od šestih mesecev.
The suitability referred to in paragraphs 1 and 2 shall be demonstrated by the food business operator through a systematic review of the available data relating to the expected benefits and to safety considerations as well as, where necessary, appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.
Primernost iz odstavkov 1 in 2 dokažejo nosilci živilske dejavnosti s sistematičnim pregledom razpoložljivih podatkov o pričakovanih koristih in varnostnih vidikih ter po potrebi z ustreznimi študijami, izvedenimi po splošno sprejetih znanstvenih smernicah za zasnovo in izvedbo takih študij.
Requirements on pesticides
Zahteve glede pesticidov
For the purposes of this Article, ‘residue’ means the residue of an active substance as referred to in Article 2(2) of Regulation (EC) No 1107/2009 used in a plant protection product as referred to in Article 2(1) of that Regulation, including metabolites and products resulting from the degradation or reaction of that active substance.
V tem členu „ostanki“ pomenijo ostanke aktivne snovi, kot so navedene v členu 2(2) Uredbe (ES) št. 1107/2009 in so uporabljene v fitofarmacevtskem sredstvu, kot je navedeno v členu 2(1) navedene uredbe, vključno z njenimi presnovki in razkrojnimi ali reakcijskimi produkti.
Infant formula and follow-on formula shall not contain residues at levels exceeding 0,01 mg/kg per active substance.
Začetne formule za dojenčke in nadaljevalne formule ne smejo vsebovati ostankov v vrednostih, višjih od 0,01 mg/kg za aktivno snov.